Telix Pharmaceuticals
Telix Pharmaceuticals is a clinical-stage biopharamaceutical company. Learn more
Launch date
Employees
Market cap
€3.8b
Enterprise valuation
€3.7b (Public information from Sep 2024)
Share price
AUD20.5 TLX.AX
Company register number 616620369
Melbourne Victoria (HQ)
No columns specified